These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37833938)
1. Amyloid-β Effects on Peripheral Nerve: A New Model System. Stecker MM; Srivastava A; Reiss AB Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833938 [TBL] [Abstract][Full Text] [Related]
2. Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System. Lucey BP; Mawuenyega KG; Patterson BW; Elbert DL; Ovod V; Kasten T; Morris JC; Bateman RJ JAMA Neurol; 2017 Feb; 74(2):207-215. PubMed ID: 27992627 [TBL] [Abstract][Full Text] [Related]
3. Synergistic interactions between Alzheimer's Aβ40 and Aβ42 on the surface of primary neurons revealed by single molecule microscopy. Chang CC; Althaus JC; Carruthers CJ; Sutton MA; Steel DG; Gafni A PLoS One; 2013; 8(12):e82139. PubMed ID: 24312636 [TBL] [Abstract][Full Text] [Related]
4. Opposite effects of low and high doses of Abeta42 on electrical network and neuronal excitability in the rat prefrontal cortex. Wang Y; Zhang G; Zhou H; Barakat A; Querfurth H PLoS One; 2009 Dec; 4(12):e8366. PubMed ID: 20027222 [TBL] [Abstract][Full Text] [Related]
5. A novel peptide prevents death in enriched neuronal cultures. Zemlyak I; Furman S; Brenneman DE; Gozes I Regul Pept; 2000 Dec; 96(1-2):39-43. PubMed ID: 11102650 [TBL] [Abstract][Full Text] [Related]
6. Soluble Amyloid-β42 Stimulates Glutamate Release through Activation of the α7 Nicotinic Acetylcholine Receptor. Hascup KN; Hascup ER J Alzheimers Dis; 2016 May; 53(1):337-47. PubMed ID: 27163813 [TBL] [Abstract][Full Text] [Related]
7. Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Kasa P; Papp H; Kovacs I; Forgon M; Penke B; Yamaguchi H Neurosci Lett; 2000 Jan; 278(1-2):117-9. PubMed ID: 10643815 [TBL] [Abstract][Full Text] [Related]
8. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model. Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W; J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262 [TBL] [Abstract][Full Text] [Related]
9. Intracellular accumulation of amyloid-β (Aβ) protein plays a major role in Aβ-induced alterations of glutamatergic synaptic transmission and plasticity. Ripoli C; Cocco S; Li Puma DD; Piacentini R; Mastrodonato A; Scala F; Puzzo D; D'Ascenzo M; Grassi C J Neurosci; 2014 Sep; 34(38):12893-903. PubMed ID: 25232124 [TBL] [Abstract][Full Text] [Related]
10. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species. Jan A; Adolfsson O; Allaman I; Buccarello AL; Magistretti PJ; Pfeifer A; Muhs A; Lashuel HA J Biol Chem; 2011 Mar; 286(10):8585-8596. PubMed ID: 21156804 [TBL] [Abstract][Full Text] [Related]
12. Nuclear translocation uncovers the amyloid peptide Aβ42 as a regulator of gene transcription. Barucker C; Harmeier A; Weiske J; Fauler B; Albring KF; Prokop S; Hildebrand P; Lurz R; Heppner FL; Huber O; Multhaup G J Biol Chem; 2014 Jul; 289(29):20182-91. PubMed ID: 24878959 [TBL] [Abstract][Full Text] [Related]
13. Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human Brain. Hey JA; Kocis P; Hort J; Abushakra S; Power A; Vyhnálek M; Yu JY; Tolar M CNS Drugs; 2018 Sep; 32(9):849-861. PubMed ID: 30076539 [TBL] [Abstract][Full Text] [Related]
14. Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention. Botella Lucena P; Vanherle S; Lodder C; Gutiérrez de Ravé M; Stancu IC; Lambrichts I; Vangheluwe R; Bruffaerts R; Dewachter I Acta Neuropathol; 2022 Sep; 144(3):489-508. PubMed ID: 35796870 [TBL] [Abstract][Full Text] [Related]
15. A traditional Chinese Medicine, YXQN, Reduces Amyloid-induced Cytotoxicity by Inhibiting Aβ42 Aggregation and Fibril Formation. Wang L; Liu S; Xu J; Watanabe N; Di J; Wei W; Mayo KH; Li J; Li X Curr Pharm Des; 2020; 26(7):780-789. PubMed ID: 32031066 [TBL] [Abstract][Full Text] [Related]
16. Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. Chen YR; Glabe CG J Biol Chem; 2006 Aug; 281(34):24414-22. PubMed ID: 16809342 [TBL] [Abstract][Full Text] [Related]
17. Increased Aβ Wang HY; Trocmé-Thibierge C; Stucky A; Shah SM; Kvasic J; Khan A; Morain P; Guignot I; Bouguen E; Deschet K; Pueyo M; Mocaer E; Ousset PJ; Vellas B; Kiyasova V Alzheimers Res Ther; 2017 Jul; 9(1):54. PubMed ID: 28750690 [TBL] [Abstract][Full Text] [Related]
18. PI3K activation prevents Aβ42-induced synapse loss and favors insoluble amyloid deposit formation. Arnés M; Romero N; Casas-Tintó S; Acebes Á; Ferrús A Mol Biol Cell; 2020 Feb; 31(4):244-260. PubMed ID: 31877058 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ. Fernandez MA; Klutkowski JA; Freret T; Wolfe MS J Biol Chem; 2014 Nov; 289(45):31043-52. PubMed ID: 25239621 [TBL] [Abstract][Full Text] [Related]
20. Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay. Lee SL; Thomas P; Fenech M Environ Mol Mutagen; 2014 Jan; 55(1):1-14. PubMed ID: 24038346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]